Tudor Investment Corp
LAB icon

Tudor Investment Corp’s Standard BioTools LAB Stock Holding History

Tudor Investment Corp’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-85,058
Closed -$164K – 2602
2023
Q2 		$164K Sell
85,058
-52,468
-38% -$104K ﹤0.01% 2258
2023
Q1 		$268K Sell
137,526
-55,111
-29% -$109K ﹤0.01% 2012
2022
Q4 		$225K Hold
192,637
– – ﹤0.01% 2073
2022
Q3 		$212K Hold
192,637
– – ﹤0.01% 2029
2022
Q2 		$308K Buy
192,637
+87,598
+83% +$217K 0.01% 1550
2022
Q1 		$377K Sell
105,039
-16,209
-13% -$56K 0.01% 1432
2021
Q4 		$475K Buy
+121,248
New +$568K 0.01% 1513
2019
Q4 		– Sell
-51,597
Closed -$239K – 1275
2019
Q3 		$239K Buy
51,597
+33,292
+182% +$262K 0.01% 921
2019
Q2 		$226K Buy
+18,305
New +$233K 0.01% 936
2019
Q1 		– Sell
-48,415
Closed -$417K – 1189
2018
Q4 		$417K Buy
+48,415
New +$377K 0.01% 655
2014
Q1 		– Sell
-11,992
Closed -$459K – 1319
2013
Q4 		$459K Buy
+11,992
New +$353K 0.02% 613

Other funds holding LAB

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Tudor Investment Corp's LAB Position: Q3 2023 in Review

Tudor Investment Corp sold out of Standard BioTools (LAB) in Q3 2023, closing a stake of 85,058 shares — an estimated $164K sold.

Tudor Investment Corp first reported a position in LAB in Q4 2013 and held it in 11 quarters. The position peaked at $475K in Q4 2021. 72 funds tracked by Wall St. Rank hold LAB as of Q3 2023.

  • Tudor Investment Corp reported no remaining Standard BioTools position as of Q3 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 85,058 Standard BioTools shares in Q3 2023, an estimated $164K.
  • Tudor Investment Corp first reported a position in Standard BioTools in Q4 2013 and held it in 11 quarters.
  • Tudor Investment Corp's Standard BioTools position peaked at $475K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2023.

Based on Tudor Investment Corp's 13F filing for Q3 2023, filed 15 Nov 2023.